Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-10 · accession 0001104659-25-058954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-12 | 2025-06-10 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | S - Sale+OE | $67.19 | -2,069 | 1,889 | -52% | -$139.0K |
| D | 2025-06-12 | 2025-06-10 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $17.97 | +1,069 | 3,958 | +37% | +$19.2K |
| D | 2025-06-12 | 2025-06-10 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -1,069 | 8,231 | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-10 | S | D | 2,069 | $67.19 | 1,889 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-10 | M | A | 1,069 | $17.97 | 3,958 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-06-10 | M | D | 1,069 | $0.00 | 8,231 | D | $17.97 · — to 2033-04-03 | 1,069 Common Stock | (F2) The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. |